Studies by Goetzl et al. showed that the ADEs of AD patients load a variety of differentially expressed proteins, including β-site APP-cleaving enzyme 1 (BACE-1), soluble amyloid precursor protein (sAPP) β and glial-derived neurotrophic factor (GDNF). Here, BACE1 is linked to Alzheimer disease.